Gujarat Themis Biosyn Share price

GUJTHEM

Healthcare Mid Cap

359.94

35.52 (10.95%)

NSE

BSE

Last updated on 24 Apr, 2026 | 15:59 IST

BUYSELL

Today's High

380.00

Today's Low

316.01

52 Week Low

225.05

52 Week High

479.00

Free Demat with Zero AMC*

Gujarat Themis Biosyn Chart

ChartIQ

TradingView

Gujarat Themis Biosyn Share Key Metrics

Volume

96.57 L

Market Cap

3922.10 CR

LTQ@LTP

1@359.94

ATP

366.77 Var Margin

25.03 %

Circuit Range

259.54-389.3

Delivery %

50.33 %

Value

354.18 CR

ASM/GSM

No

Market Lot

1

Summary

Gujarat Themis Biosyn share price stands at ₹359.94 at 24 Apr, 2026 | 15:59. The stock Gujarat Themis Biosyn intraday movement has stayed between ₹316.01 and ₹380.00, while on a 52-week basis it has fluctuated from ₹225.05 to ₹479.00.

In terms of trading activity, Gujarat Themis Biosyn has recorded a volume of 9656793 shares. The Gujarat Themis Biosyn has a market cap of ₹108965265. The stock’s Average Traded Price (ATP) stands at ₹36677, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 35994.

The Gujarat Themis Biosyn operates within a circuit range of ₹259.54-389.3 – ₹259.54-389.3, with a Value of ₹354.18 CR. The Delivery Percentage for the day is 50.33%. Additionally, Gujarat Themis Biosyn currently falls under the No framework, and trades with a market lot size of 1.

Gujarat Themis Biosyn Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

63.82

Sector P/B

3.5

Sec. Div. Yield

0.57

Gujarat Themis Biosyn Resistance and Support

Pivot 326.65

Resistance

First Resistance

330.22

Second Resistance

336.02

Third Resistance

339.59

Support

First Support

320.85

Second Support

317.28

Third Support

311.48

Gujarat Themis Biosyn Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

70.86%

Mutual Fund

1.16%

Insurance

0%

Foreign Institutional Investors

1.42%

Domestic Institutional Investors

0.01%

Retail

26.54%

Others

0.01%

Total Promoters

MAR '24

70.86%

JUN '24

70.86%

SEP '24

70.86%

DEC '24

70.86%

Gujarat Themis Biosyn Corporate Actions

Date	Agenda
2026-02-05	Quarterly Results
2025-11-10	Quarterly Results
2025-08-01	Quarterly Results
2025-05-20	Audited Results & Final Dividend
2025-02-14	Quarterly Results

Gujarat Themis Biosyn News

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn acquired 13 branded generic products from Sanofi for Euro 158 million (₹1,740 crores). This strategic acquisition aims to strengthen its global pharmaceutical platform and expand its presence in the anti-infective segment across over 55 countries.

Apr 24 2026 00:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn acquired 13 branded generic products from Sanofi for Euro 158 million (₹1,740 crores). This strategic acquisition aims to strengthen its global pharmaceutical platform and expand its presence in the anti-infective segment across over 55 countries.

Apr 23 2026 23:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Limited acquired Sanofi's global Anti-TB and Anti-Infective Portfolio for approximately €158 million. The acquired portfolio boasts €62 million in FY25 revenue, 13 established brands, and a presence in 55+ countries, structured as an asset acquisition.

Apr 23 2026 23:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Ltd (GTBL) is acquiring Sanofi's Global Anti-TB and Anti-Infective Portfolio for EUR 158 million, a strategic move to strengthen its global pharmaceuticals platform and expand into regulated markets. This acquisition, expected to close by Q3FY27, is poised to enhance GTBL's international presence.

Apr 23 2026 23:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn signed an Asset Purchase Agreement with Sanofi for Euro 158 million to acquire 13 anti-tuberculosis and anti-infective brands. This capital-efficient acquisition will strengthen its global generic pharma platform and expand its international footprint across 55+ countries.

Apr 23 2026 23:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Limited's postal ballot saw shareholders reappoint Mrs. Kirandeep Madan as an independent director with 99.996% votes in favor. They also approved material related party transactions with Themis Medicare Limited, though this resolution passed with a narrow majority of 52.5598% votes in favor.

Apr 20 2026 22:04:00

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Limited's postal ballot saw shareholders reappoint Mrs. Kirandeep Madan as an independent director with 99.996% votes in favor. They also approved material related party transactions with Themis Medicare Limited, though this resolution passed with a narrow majority of 52.5598% votes in favor.

Apr 20 2026 22:04:00

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Gujarat Themis Biosyn shareholders approved the re-appointment of an independent director and material related party transactions through postal ballot. The e-voting process concluded on April 17, 2026.

Apr 20 2026 22:04:00

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Gujarat Themis Biosyn shareholders approved the re-appointment of an independent director and material related party transactions through postal ballot. The e-voting process concluded on April 17, 2026.

Apr 20 2026 22:04:00

Gujarat Themis Biosyn Ltd - 506879 - Voting Results And Scrutinizer''s Report On Postal Ballot

Gujarat Themis Biosyn shareholders approved the re-appointment of an independent director and material related party transactions through postal ballot. The e-voting process concluded on April 17, 2026.

Apr 20 2026 22:04:00

NSE : 29731

BSE : 506879

ISIN : INE942C01045

Gujarat Themis Biosyn Management

Name	Position
Vineet G Gawankar	Company Secretary & Compliance Officer
Dinesh S Patel	Chairman

Gujarat Themis Biosyn Similar Stocks

SMS Pharmaceuticals Ltd.

396.70

-18.85 (4.54%)

Indraprastha Medical Corporation Ltd.

406.45

-0.55 (0.14%)

Artemis Medicare Services Ltd.

234.11

1.55 (0.67%)

Advanced Enzyme Technologies Ltd.

299.05

0.40 (0.13%)

Aarti Drugs Ltd.

366.70

-5.25 (1.41%)

RPG Life Sciences Ltd.

2033.10

21.70 (1.08%)

Gufic Biosciences Ltd.

298.30

1.80 (0.61%)

Bliss GVS Pharma Ltd.

262.68

-6.11 (2.27%)

Orchid Pharma Ltd.

566.85

0.05 (0.01%)

IOL Chemicals And Pharmaceuticals Ltd.

89.11

-3.47 (3.75%)

Gujarat Themis Biosyn FAQs

The Buying Price of Gujarat Themis Biosyn share is 359.94 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Gujarat Themis Biosyn stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gujarat Themis Biosyn, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Gujarat Themis Biosyn shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Gujarat Themis Biosyn shares is 0. Useful to assess the stock's value relative to its book value.

To assess Gujarat Themis Biosyn’s valuation compare Sector P/E, P/B which are 63.82 & 3.5 with sector averages, along with growth rates and financial metrics.

The Market Cap of Gujarat Themis Biosyn is 3922.10 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Gujarat Themis Biosyn share price is 479.00 & 225.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Gujarat Themis Biosyn belongs to the Healthcare sector.